Sign up for our Oncology Central weekly news round-up

PSMA PET imaging in prostate cancer: an interview with Dr Jeremie Calais

Written by Jeremie Calais (University of California, Los Angeles, CA, USA)

PSMA PET imaging

Please could you introduce yourself, your research background and your current research interests? My name is Jeremie Calais and I am a nuclear medicine physician. I was trained in France and I work now at UCLA (CA, USA). I am the Director of the Clinical Research Program of the Nuclear Medicine and Theragnostic Division at UCLA. My work focuses on improving the outcome of cancer patients by translating and applying novel diagnostic and therapeutic approaches. I use PET/CT imaging, for example, for cancer phenotyping, radiation therapy planning or therapy response assessments. Now, with the theragnostic era, which is a combination...

To view this content, please register now for access

It's completely free